Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Ambu

Ylin-
Alin-
Vaihto-
2026 Q2 -tulosraportti
76 päivää sitten
0,41 DKK/osake
Viimeisin osinko
0,58%Tuotto/v

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q3 -tulosraportti
26.8.
Menneet tapahtumat
2026 Q2 -tulosraportti
6.5.
2026 Q1 -tulosraportti
4.2.
2025 Q4 -tulosraportti
5.11.2025
2025 Q3 -tulosraportti
22.8.2025
2025 Q2 -tulosraportti
7.5.2025

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 4 t sitten
    ·
    Ambu continues the strong technical development 📈 After several days of consolidation between 68 and 70.70 kr., Ambu has now broken above the resistance zone and is trading around 71.30 kr.. This is a positive technical signal. At the same time, we see several bullish factors: -MA9 continues to be above MA20 (short-term Golden Cross). - Momentum is intact, and buyers have defended the price through the consolidation. - The price has now set a new short-term top around 71.4 kr., which could open for a test of the next resistance levels, if volume follows. It will be exciting to see if Ambu can establish itself above 71 kr. and if successful, the technical picture still looks promising. This is my personal technical analysis and not a recommendation to buy or sell.
    8 min sitten
    ·
    It is completely fair to be skeptical of technical analysis. 😊 But technical analysis is not about predicting the price on a specific day – it is about assessing probabilities. Today, virtually the entire medtech and general stock market is under pressure, so a decline in Ambu after a rise of around 20 % over a few weeks is not unusual. On the contrary, it is often healthy for a stock to take a break or correct a little after a strong rally. The interesting thing is therefore not a single trading day, but whether Ambu continues to hold the most important support levels and the rising trend. As long as that is the case, the technical picture, in my assessment, remains constructive. Technical analysis provides no guarantees and merely helps to put probabilities on market behavior. Good day 🌞
  • 1 päivä sitten
    What is going on when it is go down again ?!
    21 t sitten · Muokattu
    ·
    That's what it's about, that you should buy when it's down and on its way up, and sell before it goes down. Because then you can get the optimal gain and have time to invest elsewhere, and in that way use your time well.
  • 3 päivää sitten
    ·
    My advice to investors who do not own shares in Ambu. You should not buy Ambu - I have been there for 25 years, never anything positive. I naively thought it would get better with Britt Meelby. But we are at the same place on the stock chart as 10 years ago.
    22 t sitten
    ·
    Things have improved in the company but not the share price, ambu has not been financially better than they are now.
  • 3 päivää sitten
    ·
    Impressive debate. It's approx. 30 days since a user wrote a post based on the business Ambu, otherwise it's only comments on the daily price, crosses and moving averages. Investing anno 2026 is like a discussion on the old Nationen, which even ekstrabladet.dk grew out of.
    20 t sitten
    ·
    Agreed. The level here is generally shockingly low. Most "debaters" are totally clueless. Therefore, one should generally not act on advice or views aired here at all. This should, if applicable, only happen extremely selectively, once one has investigated the debaters' seriousness and general character.
  • 3 päivää sitten · Muokattu
    ·
    Bought more on this dip today. Michael Friis Jørgensen from HC Andersen Capital has previously said that Ambu could cost anywhere between 60 and 600. The 600 has, however, been adjusted down to 400, but that's probably okay too.
    1 päivä sitten
    ·
    I also just blindly follow what Michael Friis Jørgensen says. Then you also have someone to blame if it fails.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q2 -tulosraportti
76 päivää sitten
0,41 DKK/osake
Viimeisin osinko
0,58%Tuotto/v

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 4 t sitten
    ·
    Ambu continues the strong technical development 📈 After several days of consolidation between 68 and 70.70 kr., Ambu has now broken above the resistance zone and is trading around 71.30 kr.. This is a positive technical signal. At the same time, we see several bullish factors: -MA9 continues to be above MA20 (short-term Golden Cross). - Momentum is intact, and buyers have defended the price through the consolidation. - The price has now set a new short-term top around 71.4 kr., which could open for a test of the next resistance levels, if volume follows. It will be exciting to see if Ambu can establish itself above 71 kr. and if successful, the technical picture still looks promising. This is my personal technical analysis and not a recommendation to buy or sell.
    8 min sitten
    ·
    It is completely fair to be skeptical of technical analysis. 😊 But technical analysis is not about predicting the price on a specific day – it is about assessing probabilities. Today, virtually the entire medtech and general stock market is under pressure, so a decline in Ambu after a rise of around 20 % over a few weeks is not unusual. On the contrary, it is often healthy for a stock to take a break or correct a little after a strong rally. The interesting thing is therefore not a single trading day, but whether Ambu continues to hold the most important support levels and the rising trend. As long as that is the case, the technical picture, in my assessment, remains constructive. Technical analysis provides no guarantees and merely helps to put probabilities on market behavior. Good day 🌞
  • 1 päivä sitten
    What is going on when it is go down again ?!
    21 t sitten · Muokattu
    ·
    That's what it's about, that you should buy when it's down and on its way up, and sell before it goes down. Because then you can get the optimal gain and have time to invest elsewhere, and in that way use your time well.
  • 3 päivää sitten
    ·
    My advice to investors who do not own shares in Ambu. You should not buy Ambu - I have been there for 25 years, never anything positive. I naively thought it would get better with Britt Meelby. But we are at the same place on the stock chart as 10 years ago.
    22 t sitten
    ·
    Things have improved in the company but not the share price, ambu has not been financially better than they are now.
  • 3 päivää sitten
    ·
    Impressive debate. It's approx. 30 days since a user wrote a post based on the business Ambu, otherwise it's only comments on the daily price, crosses and moving averages. Investing anno 2026 is like a discussion on the old Nationen, which even ekstrabladet.dk grew out of.
    20 t sitten
    ·
    Agreed. The level here is generally shockingly low. Most "debaters" are totally clueless. Therefore, one should generally not act on advice or views aired here at all. This should, if applicable, only happen extremely selectively, once one has investigated the debaters' seriousness and general character.
  • 3 päivää sitten · Muokattu
    ·
    Bought more on this dip today. Michael Friis Jørgensen from HC Andersen Capital has previously said that Ambu could cost anywhere between 60 and 600. The 600 has, however, been adjusted down to 400, but that's probably okay too.
    1 päivä sitten
    ·
    I also just blindly follow what Michael Friis Jørgensen says. Then you also have someone to blame if it fails.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q3 -tulosraportti
26.8.
Menneet tapahtumat
2026 Q2 -tulosraportti
6.5.
2026 Q1 -tulosraportti
4.2.
2025 Q4 -tulosraportti
5.11.2025
2025 Q3 -tulosraportti
22.8.2025
2025 Q2 -tulosraportti
7.5.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q2 -tulosraportti
76 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q3 -tulosraportti
26.8.
Menneet tapahtumat
2026 Q2 -tulosraportti
6.5.
2026 Q1 -tulosraportti
4.2.
2025 Q4 -tulosraportti
5.11.2025
2025 Q3 -tulosraportti
22.8.2025
2025 Q2 -tulosraportti
7.5.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

0,41 DKK/osake
Viimeisin osinko
0,58%Tuotto/v

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 4 t sitten
    ·
    Ambu continues the strong technical development 📈 After several days of consolidation between 68 and 70.70 kr., Ambu has now broken above the resistance zone and is trading around 71.30 kr.. This is a positive technical signal. At the same time, we see several bullish factors: -MA9 continues to be above MA20 (short-term Golden Cross). - Momentum is intact, and buyers have defended the price through the consolidation. - The price has now set a new short-term top around 71.4 kr., which could open for a test of the next resistance levels, if volume follows. It will be exciting to see if Ambu can establish itself above 71 kr. and if successful, the technical picture still looks promising. This is my personal technical analysis and not a recommendation to buy or sell.
    8 min sitten
    ·
    It is completely fair to be skeptical of technical analysis. 😊 But technical analysis is not about predicting the price on a specific day – it is about assessing probabilities. Today, virtually the entire medtech and general stock market is under pressure, so a decline in Ambu after a rise of around 20 % over a few weeks is not unusual. On the contrary, it is often healthy for a stock to take a break or correct a little after a strong rally. The interesting thing is therefore not a single trading day, but whether Ambu continues to hold the most important support levels and the rising trend. As long as that is the case, the technical picture, in my assessment, remains constructive. Technical analysis provides no guarantees and merely helps to put probabilities on market behavior. Good day 🌞
  • 1 päivä sitten
    What is going on when it is go down again ?!
    21 t sitten · Muokattu
    ·
    That's what it's about, that you should buy when it's down and on its way up, and sell before it goes down. Because then you can get the optimal gain and have time to invest elsewhere, and in that way use your time well.
  • 3 päivää sitten
    ·
    My advice to investors who do not own shares in Ambu. You should not buy Ambu - I have been there for 25 years, never anything positive. I naively thought it would get better with Britt Meelby. But we are at the same place on the stock chart as 10 years ago.
    22 t sitten
    ·
    Things have improved in the company but not the share price, ambu has not been financially better than they are now.
  • 3 päivää sitten
    ·
    Impressive debate. It's approx. 30 days since a user wrote a post based on the business Ambu, otherwise it's only comments on the daily price, crosses and moving averages. Investing anno 2026 is like a discussion on the old Nationen, which even ekstrabladet.dk grew out of.
    20 t sitten
    ·
    Agreed. The level here is generally shockingly low. Most "debaters" are totally clueless. Therefore, one should generally not act on advice or views aired here at all. This should, if applicable, only happen extremely selectively, once one has investigated the debaters' seriousness and general character.
  • 3 päivää sitten · Muokattu
    ·
    Bought more on this dip today. Michael Friis Jørgensen from HC Andersen Capital has previously said that Ambu could cost anywhere between 60 and 600. The 600 has, however, been adjusted down to 400, but that's probably okay too.
    1 päivä sitten
    ·
    I also just blindly follow what Michael Friis Jørgensen says. Then you also have someone to blame if it fails.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt